Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NB170867

Novus Biologicals™ CD23/Fc epsilon RII Recombinant Protein Antigen
SDP

Catalog No. NB170867 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB170867 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. NB170867 Supplier Novus Biologicals™ Supplier No. NBP316985PEP
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Recombinant Protein

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1M Urea, pH 7.4.
Gene ID (Entrez) 2208
Molecular Weight (g/mol) M.W. Theoretical: 27 kDa
Quantity 100 μg
Storage Requirements Store at -20°C. Avoid freeze-thaw cycles.
Gene Alias BLAST-2, CD23A, CD23CD23 antigen, CLEC4JC-type lectin domain family 4 member J, C-type lectin domain family 4, member J, Fc fragment of IgE, low affinity II, receptor for (CD23), FCE2Fc fragment of IgE, low affinity II, receptor for (CD23A), fc-epsilon-RII, IGEBF, Immunoglobulin E-binding factor, low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor
Gene Symbol FCER2
Research Category Adaptive Immunity, B Cell Development and Differentiation Markers, Biologically Active Proteins, Cancer, Immunology
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein CD23/Fc epsilon RII
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.